Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

8,017 public trials 743 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04718389

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Scottsboro, Alabama, United States

GSK Investigational Site Litchfield Park, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 397 locations

View Trial Details

Completed

Description of the Ability to Learn How to Handle Inhaler Devices in COPD

NCT02813200

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations: CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque Bordeaux, France

View Trial Details

Completed

Anti-Platelets in Chronic Obstructive Pulmonary Disease

NCT05567562

Conditions: COPD, Chronic Disease, Disease Attributes, +8 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Sleeping Position Study in COPD Patients

NCT04963205

Conditions: COPD, Chronic Disease, Disease Attributes, +7 more
Locations: COPD-center, Sahlgrenska University Hospital Gothenburg, VGR, Sweden

View Trial Details

Completed

Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

NCT04187976

Conditions: Asthma, Bronchial Diseases, Chronic Sinusitis, +15 more
Locations: CHU Lille Lille, France

View Trial Details

Completed

Home-monitored Telerehabilitation in COPD Patients

NCT04816825

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: COPD-Center Gothenburg, VGR, Sweden

View Trial Details

Completed

Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)

NCT00920621

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Robert Zeiger, MD San Diego, California, United States

George O'Connor, MD Boston, Massachusetts, United States

Leonard Bacharier, MD St Louis, Missouri, United States

View Trial Details

Completed

Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)

NCT03888131

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Site 15604 - Anhui Provincial Hospital Hefei, Anhui, China

Site 15635 - The Second Hospital of Anhui Medical Hospital Hefei, Anhui, China

Site 15613 - Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

Site 15611 - Xuanwu Hospital Capital Medical University Beijing, Beijing Municipality, China

View all 53 locations

View Trial Details

Completed

Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)

NCT00861926

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Chiesi Site No 103 Burgas, Bulgaria

Chiesi Site No 107 Pleven, Bulgaria

Chiesi Site No 105 Plovdiv, Bulgaria

Chiesi Site No 111 Plovdiv, Bulgaria

View all 206 locations

View Trial Details

Completed

A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD

NCT05138250

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: Clinical Research Facility - NGH Sheffield, S Yorkshire, United Kingdom

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions